Kanavos P - Search Results

1

Higher US branded drug prices and spending compared to other countries may stem partly from quick uptake of new drugs.

Kanavos P, Ferrario A, Vandoros S, Anderson GF. Kanavos P, et al. Health Aff (Millwood). 2013 Apr;32(4):753-61. doi: 10.1377/hlthaff.2012.0920. Health Aff (Millwood). 2013. PMID: 23569056

2

Reference pricing for drugs: is it compatible with U.S. health care?

Kanavos P, Reinhardt U. Kanavos P, et al. Health Aff (Millwood). 2003 May-Jun;22(3):16-30. doi: 10.1377/hlthaff.22.3.16. Health Aff (Millwood). 2003. PMID: 12757268

3

Senior citizens and the burden of prescription drug outlays: what lessons for the Medicare prescription drug benefit?

Kanavos P, Gemmill M. Kanavos P, et al. Appl Health Econ Health Policy. 2004;3(4):217-27. doi: 10.2165/00148365-200403040-00005. Appl Health Econ Health Policy. 2004. PMID: 15901196

4

Do generics offer significant savings to the UK National Health Service?

Kanavos P. Kanavos P. Curr Med Res Opin. 2007 Jan;23(1):105-16. doi: 10.1185/030079907X159506. Curr Med Res Opin. 2007. PMID: 17257472

5

[Constrained competition in parallel drug importation: the case of simvastatin in Germany, the Netherlands, and the United Kingdom].

Costa-Font J, Kanavos P. Costa-Font J, et al. Among authors: kanavos p. Gac Sanit. 2007 Jan-Feb;21(1):53-9. doi: 10.1157/13099121. Gac Sanit. 2007. PMID: 17306187 Free article. Spanish.

6

Benefits of global partnerships to facilitate access to medicines in developing countries: a multi-country analysis of patients and patient outcomes in GIPAP.

Kanavos P, Vandoros S, Garcia-Gonzalez P. Kanavos P, et al. Global Health. 2009 Dec 31;5:19. doi: 10.1186/1744-8603-5-19. Global Health. 2009. PMID: 20043820 Free PMC article.

7

Determinants of branded prescription medicine prices in OECD countries.

Kanavos PG, Vandoros S. Kanavos PG, et al. Health Econ Policy Law. 2011 Jul;6(3):337-67. doi: 10.1017/S1744133111000090. Health Econ Policy Law. 2011. PMID: 21676345 Free article.

8

The effects of drug market regulation on pharmaceutical prices in Europe: overview and evidence from the market of ACE inhibitors.

von der Schulenburg F, Vandoros S, Kanavos P. von der Schulenburg F, et al. Among authors: kanavos p. Health Econ Rev. 2011 Nov 21;1(1):18. doi: 10.1186/2191-1991-1-18. Health Econ Rev. 2011. PMID: 22828053 Free PMC article.

9

Epidemiology, management, complications and costs associated with type 2 diabetes in Brazil: a comprehensive literature review.

Bertoldi AD, Kanavos P, França GV, Carraro A, Tejada CA, Hallal PC, Ferrario A, Schmidt MI. Bertoldi AD, et al. Among authors: kanavos p. Global Health. 2013 Dec 3;9:62. doi: 10.1186/1744-8603-9-62. Global Health. 2013. PMID: 24299125 Free PMC article. Review.

10

Dealing with uncertainty and high prices of new medicines: a comparative analysis of the use of managed entry agreements in Belgium, England, the Netherlands and Sweden.

Ferrario A, Kanavos P. Ferrario A, et al. Among authors: kanavos p. Soc Sci Med. 2015 Jan;124:39-47. doi: 10.1016/j.socscimed.2014.11.003. Epub 2014 Nov 5. Soc Sci Med. 2015. PMID: 25461860

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

143 results

Search Page

Filters